2-Bromo-5-hydroxyphenylporphyrins for photodynamic therapy: Photosensitization efficiency, subcellular localization and in vivo studies

Photodiagnosis and Photodynamic Therapy

Volumn 10, Issue 1, 2013, Pages 51-61

  Laranjo, Mafalda ^a,b   Serra, Arménio C ^c   Abrantes, Margarida ^a,b   Piñeiro, Marta ^c   Gonçalves, Ana C ^b   Casalta Lopes, João ^a   Carvalho, Lina ^b   Sarmento Ribeiro, Ana B ^b   Rocha Gonsalves, António ^b,c   Botelho, Filomena ^a,b  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Colorectal adenocarcinoma; Melanoma; Photochemotherapy; Porphyrins; Reactive oxygen species

Indexed keywords

2 BROMO 5 HYDROXYPHENYLPORPHYRIN; 5,10,15,20 TETRAKIS(2 BROMO 5 HYDROXYPHENYL)PORPHYRIN; 5,15 BIS(2 BROMO 5 HYDROXYPHENYL)PORPHYRIN; BROMINE; DIARYL KETONE; PORPHYRIN DERIVATIVE; REACTIVE OXYGEN METABOLITE; TETRAARYL BROMINATED PORPHYRIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER SURGERY; CELL ASSAY; CELL CULTURE; CELL DEATH; CELL DISRUPTION; CELL PROLIFERATION; CELL THERAPY; CELLULAR DISTRIBUTION; COLORECTAL CARCINOMA; CONTROLLED STUDY; CYTOTOXICITY; FLOW CYTOMETRY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; IRRADIATION; KAPLAN MEIER METHOD; MALE; MELANOMA; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NONHUMAN; OXIDATIVE STRESS; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR XENOGRAFT;

ANIMALS; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; SUBCELLULAR FRACTIONS; SURVIVAL ANALYSIS; SURVIVAL RATE; TISSUE DISTRIBUTION; TREATMENT OUTCOME;

MUS;

EID: 84875392214     PISSN: 15721000     EISSN: 18731597     Source Type: Journal    
DOI: 10.1016/j.pdpdt.2012.05.003     Document Type: Article

References (53)

1. Agostinis P., Berg K., Cengel K.A., et al. Photodynamic therapy of cancer: an update. Cancer Journal for Clinicians 2011, 61:250-281.
2. Serra A., Pineiro M., Pereira N., et al. A look at clinical applications and developments of photodynamic therapy. Oncology Reviews 2008, 2:235-249.
3. Allison R., Moghissi K., Downie G., Dixon K. Photodynamic therapy (PDT) for lung cancer. Photodiagnosis and Photodynamic Therapy 2011, 8:231-239.
4. Mroz P., Yaroslavsky A., Kharkwal G.B., Hamblin M.R. Cell death pathways in photodynamic therapy of cancer. Cancers 2011, 3:2516-2539.
5. Castano A., Demidova T., Hamblin M. Mechanisms in photodynamic therapy: part one? Photosensitizers, photochemistry and cellular localization. Photodiagnosis and Photodynamic Therapy 2004, 1:279-293.
6. Plaetzer K., Krammer B., Berlanda J., Berr F., Kiesslich T. Photophysics and photochemistry of photodynamic therapy: fundamental aspects. Lasers in Medical Science 2009, 24:259-268.
7. Huang Z., Xu H., Meyers A.D., et al. Photodynamic therapy for treatment of solid tumors - potential and technical challenges. Technology in Cancer Research and Treatment 2008, 7:309-320.
8. O'Connor A.E., Gallagher W.M., Byrne A.T. Porphyrin and nonporphyrin photosensitizers in oncology: preclinical and clinical advances in photodynamic therapy. Photochemistry and Photobiology 2009, 85:1053-1074.
9. Triesscheijn M., Baas P., Schellens J.H., Stewart F.A. Photodynamic therapy in oncology. The Oncologist 2006, 11:1034-1044.
10. ®, 5,10,15,20-tetra(m-hydroxyphenyl)chlorin)-a second-generation photosensitizer. Photochemistry and Photobiology 2011, 87:1240-1296.
11. Songca S.P. In vitro activity and tissue distribution of new fluorinated meso-tetrahydroxyphenylporphyrin photosensitizers. Journal of Pharmacy and Pharmacology 2001, 53:1469-1475.
12. Banfi S., Caruso E., Buccafurni L., et al. Comparison between 5,10,15,20-tetraaryl- and 5,15-diarylporphyrins as photosensitizers: synthesis, photodynamic activity, and quantitative structure-activity relationship modeling. Journal of Medicinal Chemistry 2006, 49:3293-3304.
13. Serra A., Piñeiro M., Santos C.I., et al. In vitro photodynamic activity of 5,15-bis(3-hydroxyphenyl)porphyrin and its halogenated derivatives against cancer cells. Photochemistry and Photobiology 2010, 86:206-212.
14. Gariboldi M.B., Ravizza R., Baranyai P., et al. Photodynamic effects of novel 5,15-diaryl-tetrapyrrole derivatives on human colon carcinoma cells. Bioorganic and Medicinal Chemistry 2009, 17:2009-2016.
15. Serra A.C., Piñeiro M., Rocha-Gonsalves, et al. Halogen atom effect on photophysical and photodynamic characteristics of derivatives of 5,10,15,20-tetrakis(3-hydroxyphenyl)porphyrin. Journal of Photochemistry and Photobiology B 2008, 92:59-65.
16. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods 1983, 65:55-63.
17. Aubry J.P., Blaecke A., Lecoanet-Henchoz S., et al. Annexin V used for measuring apoptosis in the early events of cellular cytotoxicity. Cytometry 1999, 37:197-204.
18. Abrantes A.M., Serra M.E., Gonçalves A.C., et al. Hypoxia-induced redox alterations and their correlation with 99mTc-MIBI and 99mTc-HL-91 uptake in colon cancer cells. Nuclear Medicine and Biology 2010, 37:125-132.
19. Ling H., Fu L.I., Iao Y.X., et al. Involvement of mitochondrial pathway in triptolide-induced cytotoxicity in human normal liver L-02 cells. Biological and Pharmaceutical Bulletin 2008, 31:592-597.
20. Tarpey M.M., Wink D.A., Grisham M.B. Methods for detection of reactive metabolites of oxygen and nitrogen: in vitro and in vivo considerations. American Journal of Physiology 2004, 286:431-444.
21. Dikalov S., Griendling K.K., Harrison D.G. Measurement of reactive oxygen species in cardiovascular studies. Hypertension 2007, 49:717-727.
22. Zhao H., Joseph J., Fales H.M., et al. Detection and characterization of the product of hydroethidine and intracellular superoxide by HPLC and limitations of fluorescence. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:5727-5732.
23. Dagrosa M., Viaggi M., Longhino J., et al. Experimental application of boron neutron capture therapy to undifferentiated thyroid carcinoma. International Journal of Radiation Oncology 2003, 57:1084-1092.
24. Yoon C.J., Chung J.W., Park J.H., et al. Transcatheter arterial embolization with 188Rhenium-HDD-labeled iodized oil in rabbit VX2 liver tumor. Journal of Vascular and Interventional Radiology 2004, 15:1121-1128.
25. Abrantes A.M., Rio Serra M.E., Gonçalves C., et al. Tumour hypoxia and technetium tracers: in vivo studies. Current Radiopharmaceuticals 2012, 5:99-105.
26. Bourré L., Thibaut S., Fimiani M., Ferrand Y., Simonneaux G., Patrice T. In vivo photosensitizing efficiency of a diphenylchlorin sensitizer: interest of a DMPC liposome formulation. Pharmacological Research 2003, 47:253-261.
27. Ferrand Y., Bourré L., Simonneaux G. Hydroporphyrins as tumour photosensitizers: synthesis and photophysical studies of 2,3-dihydro-5,15-di(3,5-dihydroxyphenyl) porphyrin. Bioorganic and Medicinal Chemistry Letters 2003, 13:833-835.
28. Berenbaum M.C., Akande S.L., Bonnett R., et al. Meso-tetra(hydroxyphenyl)porphyrins, a new class of potent tumour photosensitisers with favourable selectivity. British Journal of Cancer 1986, 54:717-725.
29. Azenha E.G., Serra A.C., Pineiro M., et al. Heavy-atom effects on metalloporphyrins and polyhalogenated porphyrins. Chemical Physics 2002, 280:177-190.
30. Piñeiro M., Carvalho A.L., Pereira M.M., Rocha-Gonsalves A.M., Arnaut L.G., Formosinho S.J. Photoacoustic measurements of porphyrin triplet-state quantum yields and singlet-oxygen efficiencies. Chemistry - A European Journal 1998, 4:2299-2307.
31. Leung W.N., Sun X., Mak N.K., Yow C.M. Photodynamic effects of mTHPC on human colon adenocarcinoma cells: photocytotoxicity, subcellular localization and apoptosis. Photochemistry and Photobiology 2002, 75:406-411.
32. Marchal S., Bezdetnaya L., Guillemin F. Modality of cell death induced by Foscan-based photodynamic treatment in human colon adenocarcinoma cell line HT29. Biochemistry 2004, 69:45-49.
33. Robertson C.A., Evans D.H., Abrahamse H. Photodynamic therapy (PDT): a short review on cellular mechanisms and cancer research applications for PDT. Journal of Photochemistry and Photobiology B 2009, 96:1-8.
34. Uzdensky A.B., Ma L.M., Iani V., Hjortland G.O., Steen H.B., Moan J. Intracellular localisation of hypericin in human glioblastoma and carcinoma cell lines. Lasers in Medical Science 2001, 16:276-283.
35. Kolarova H., Lenobel R., Kolar P., Strnad M. Sensitivity of different cell lines to phototoxic effect of disulfonated chloroaluminium phthalocyanine. Toxicology in Vitro 2007, 21:1304-1306.
36. Kolarova H., Nevrelova P., Bajgar R., Jirova D., Kejlova K., Strnad M. In vitro photodynamic therapy on melanoma cell lines with phthalocyanine. Toxicology in Vitro 2007, 21:249-253.
37. Picard N., Ali H., van Lier J.E., Klarskov K., Paquette B. Bromines on N-allyl position of cationic porphyrins affect both radio- and photosensitizing properties. Photochemical & Photobiological Sciences 2009, 8:224-232.
38. Gryshuk A.L., Chen Y., Potter W., Ohulchansky T., Oseroff A., Pandey R.K. In vivo stability and photodynamic efficacy of fluorinated bacteriopurpurinimides derived from bacteriochlorophyll-a. Journal of Medicinal Chemistry 2006, 49:1874-1881.
39. Osterloh J., Vicente M.G.H. Mechanisms of porphyrinoid localization in tumors. Journal of Porphyrins and Phthalocyanines 2002, 6:305-324.
40. Marchal S., Fadloun A., Maugain E., D'Hallewin M.E., Guillemin F., Bezdetnaya L. Necrotic and apoptotic features of cell death in response to Foscan photosensitization of HT29 monolayer and multicell spheroids. Biochemical Pharmacology 2005, 69:1167-1176.
41. Banfi S., Caruso E., Caprioli S., et al. Photodynamic effects of porphyrin and chlorin photosensitizers in human colon adenocarcinoma cells. Bioorganic & Medicinal Chemistry 2004, 12:4853-4860.
42. Dougherty T.J., Gomer C.J., Henderson B.W., et al. Photodynamic therapy. Journal of the National Cancer Institute 1998, 90:889-905.
43. Leist M., Nicotera P. The shape of cell death. Biochemical and Biophysical Research Communications 1997, 236:1-9.
44. Mikes J., Kleban J., Sacková V., et al. Necrosis predominates in the cell death of human colon adenocarcinoma HT-29 cells treated under variable conditions of photodynamic therapy with hypericin. Photochemical & Photobiological Sciences 2007, 6:758-766.
45. Robertson C.A., Tech M., Abrahamse H. The in vitro PDT efficacy of a novel metallophthalocyanine (MPc) derivative and established 5-ALA photosensitizing dyes against human metastatic melanoma cells. Lasers in Surgery and Medicine 2011, 24:766-776.
46. Rodrigues N.R., Rowan A., Smith M.E., et al. p53 mutations in colorectal cancer. Proceedings of the National Academy of Sciences of the United States of America 1990, 87:7555-7559.
47. Castano A., Demidova T., Hamblin M. Mechanisms in photodynamic therapy: part two-cellular signaling, cell metabolism and modes of cell death. Photodiagnosis and Photodynamic Therapy 2005, 2:1-23.
48. Castano A.P., Mroz P., Hamblin M.R. Photodynamic therapy and anti-tumour immunity. Nature Reviews Cancer 2006, 6:535-545.
49. Peng Q., Warloe T., Moan J., et al. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts. Cancer Research 2001, 61:5824-5832.
50. Stott B., Korbelik M. Activation of complement C3, C5, and C9 genes in tumors treated by photodynamic therapy. Cancer Immunology, Immunotherapy 2007, 56:649-658.
51. Schaffer M., Schaffer P.M., Corti L., et al. Photofrin as a specific radiosensitizing agent for tumors: studies in comparison to other porphyrins, in an experimental in vivo model. Journal of Photochemistry and Photobiology B 2002, 66:157-164.
52. Lim Y., Yoo J., Park D., et al. Antitumor effect of photodynamic therapy with chlorin-based photosensitizer DH-II-24 in colorectal carcinoma. Cancer Science 2009, 100:2431-2436.
53. Hajri A., Wack S., Meyer C., et al. In vitro and in vivo efficacy of photofrin and pheophorbide a, a bacteriochlorin, in photodynamic therapy of colonic cancer cells. Photochemistry and Photobiology 2002, 75:140-148.